PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
Trial ID or NCT#
NCT02571907
Status
NOT RECRUITING
Purpose
The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
Official Title
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- * An aortioiliac or iliac aneurysm* An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the common lilac artery
Exclusion Criteria:
- * Less than 18 years of age* Inability or refusal to give informed consent* Disease considerations that would compromise patient safety or study outcomes* Pregnant, breast-feeding or planning on becoming pregnant prior to completion of the study* Unwilling or unable to comply with the follow-up schedule* Simultaneously participating in another investigative device or drug study
Investigator(s)
View on ClinicalTrials.gov
